Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
ANI Pharma Inc
(NQ:
ANIP
)
62.94
-0.31 (-0.50%)
Streaming Delayed Price
Updated: 11:16 AM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ANI Pharma Inc
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 16, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Upgrades
Via
Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 16, 2022
Via
Benzinga
ANI Pharmaceuticals: Q2 Earnings Insights
August 08, 2022
ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q2 earnings results on Monday, August 8, 2022 at 06:50 AM. Here's what investors need to know about the announcement.
Via
Benzinga
ANI Pharmaceuticals: Q1 Earnings Insights
May 10, 2022
ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:50 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 16, 2022
Via
Benzinga
ANI Pharmaceuticals's Return On Capital Employed Overview
June 08, 2022
According to data from Benzinga Pro, during Q1, ANI Pharmaceuticals's (NASDAQ:ANIP) reported sales totaled $64.48 million. Despite a 16.6% increase in earnings, the company posted a loss of $20.13...
Via
Benzinga
ANI Pharmaceuticals Q1 2022 Earnings Conference Call On May 10, 2022 At 08:30 AM ET
May 06, 2022
ANI Pharmaceuticals (NASDAQ:ANIP) will host a conference call at 08:30 AM ET on May 10, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
Insider Weekends: Return Of The Meme Stocks - GameStop (GME) And AMC Entertainment (AMC)
March 28, 2022
Via
Benzinga
ANI Pharmaceuticals's Return On Capital Employed Insights
March 16, 2022
ANI Pharmaceuticals (NASDAQ:ANIP) brought in sales totaling $60.93 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 442.75%, resulting in...
Via
Benzinga
68 Biggest Movers From Yesterday
March 16, 2022
Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Rises Over 200 Points; ANI Pharmaceuticals Shares Slide
March 15, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 350 points on Tuesday. The Dow traded up 1.07% to 33,297.32 while the NASDAQ rose 1.81% to 12,809....
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 15, 2022
Gainers Incannex Healthcare (NASDAQ:IXHL) stock rose 164.2% to $60.5 during Tuesday's regular session. Incannex Healthcare's stock is trading at a volume of 664.5K...
Via
Benzinga
Upbeat Inflation Data, Falling Oil Prices Prop Up Dow
March 15, 2022
Wall Street is eyeing an upbeat session, with the Dow Jones Industrial Average up 377 points at midday.
Via
Talk Markets
Mid-Day Market Update: Dow Surges Over 300 Points; Crude Oil Tumbles 8%
March 15, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq gaining more than 200 points on Tuesday. The Dow traded up 1.01% to 33,276.46 while the NASDAQ rose 1.92% to 12,...
Via
Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
March 15, 2022
Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of...
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; US Producer Prices Increase 0.8% In February
March 15, 2022
U.S. stocks opened higher this morning, with the Dow Jones surging more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.69% to 33,172.42...
Via
Benzinga
ANI Pharma Posts Mixed Bag Q4 Earnings, FY22 Sales Outlook Trails Street Consensus
March 15, 2022
ANI Pharmaceuticals Inc's (NASDAQ: ANIP) Q4 revenues were $60.9 million, +6.4% Y/Y, beating the consensus of $56.30 million. Net revenues for generic pharmaceutical...
Via
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
ANI Pharmaceuticals: Q4 Earnings Insights
March 15, 2022
ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q4 earnings results on Tuesday, March 15, 2022 at 06:50 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Scheduled For March 15, 2022
March 15, 2022
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi...
Via
Benzinga
ANI Pharmaceuticals's Earnings Outlook
March 14, 2022
ANI Pharmaceuticals (NASDAQ:ANIP) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances
January 05, 2022
Photo by David Matos on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...
Via
Benzinga
The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail
December 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CytomX Mid-Phase Study Of ADC In Lung And Head & Neck Cancer Patients...
Via
Benzinga
Mobile Clinics Featuring Novel Mental Health Treatments Reportedly Coming to Florida and Nevada
December 20, 2021
Photo by Insung Yoon on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
7 of the Best Small-Cap Stocks to Buy Before 2022
December 16, 2021
With 2021 coming to a close and a new year upon us, it's time to get a head start on some of the best small-cap stocks to buy.
Via
InvestorPlace
This Biotech Company Specializing in Brain Disorder Treatments Reports a Stronger Cash Position
December 13, 2021
Photo by Hal Gatewood on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021
November 02, 2021
Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE:
Via
Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.